apd-334
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02447302)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
S1PR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3544938 ↗
Also known as
- apd334
- apd334
- apd334
- apd-334
- apd-334
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03072953 | Phase 2 | Jun 7, 2017 | Arena Pharmaceuticals |
| NCT03139032 | Phase 2 | May 1, 2017 | Arena Pharmaceuticals |
| NCT03155932 | Phase 2 | May 1, 2017 | Arena Pharmaceuticals |
| NCT02536404 | Phase 2 | Nov 1, 2015 | Arena Pharmaceuticals |
| NCT02447302 | Phase 2 | Jul 1, 2015 | Arena Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arena Pharmaceuticals | For profit | 5 | 5 | 1 | 2015 |
1 organizations
Page 1 / 1